Render Target: STATIC
Render Timestamp:
3/31/2025, 7:31:37 AM EDT
3/31/2025, 11:31:37 AM UTC
Commit: 461ca8d8fe5b1efd4c01fc87e5b5eb592e2d154a
XML generation date: 2025-03-07 13:15:34.347
Product last modified at: 2025-01-01T09:05:06.957Z
Cell Signaling Technology Logo
1% for the planet logo
PDP - Template Name: Polyclonal Antibody
PDP - Template ID: *******59c6464

CRAD Antibody #39862

Filter:
  • WB
  • IP

    Supporting Data

    REACTIVITY H
    SENSITIVITY Endogenous
    MW (kDa) 200
    SOURCE Rabbit
    Application Key:
    • WB-Western Blotting 
    • IP-Immunoprecipitation 
    Species Cross-Reactivity Key:
    • H-Human 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000
    Immunoprecipitation 1:50

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    CRAD Antibody recognizes endogenous levels of total CRAD protein.

    Species Reactivity:

    Human

    Source / Purification

    Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Pro200 of human CRAD protein. Antibodies are purified by peptide affinity chromatography.

    Background

    Cancer-related regulator of actin dynamics (CRAD, also CRACD, KIAA1211) regulates actin polymerization and epithelial integrity by sequestering actin capping proteins CAPZA and CAPZB. CRAD stabilizes the β-catenin/E-cadherin complex. Loss of CRAD allows β-catenin to activate wnt signaling (1).
    While CRAD was identified as a tumor suppressor downregulated in colorectal cancer, its expression is upregulated in other human cancers, including non-small cell lung cancer (NSCLC) and breast cancer (1-3). In NSCLC cells, downregulation of CRAD inhibits proliferation and increases the rate of apoptosis (2). Mutation of CRAD in small cell lung cancer (SCLC) may serve as a prognostic marker for overall survival (4).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    XP is a registered trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.